Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over ...

The $7 million KidSTREAM museum was the brainchild of a former teacher looking for a place to entertain her young daughters.

Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy ...

Interest in longevity medicine has exploded in recent years. Here's who's at the forefront of longevity science, investment, ...

Issued on behalf of VisionWave Holdings, Inc., Starfighters Space, Inc., Avaí Bio, Inc., Lake Victoria Gold Ltd., and QSE – Quantum Secure ...

Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery April 30, 2026 8:30 AM ...

AVAI, BIOA, NAGE, LLY, and NVO Lead a New Wave of Metabolic and Molecular Anti-Aging Therapies Issued on behalf of Avaí Bio, Inc. Companies mentioned in this article: Avaí Bio, Inc. (OTCQB: AVAI), ...

Interest in longevity medicine has exploded in recent years. Here's who's at the forefront of longevity science, investment, ...

Ariane Jansma, Point Loma Nazarene University professor of chemistry and a woman who has spent more than a decade researching ...

AI is transforming research. These AI tools for research will help you keep up with the times and take your research to the next level.

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine.

This sale represented 6.76% of De Backer's total holdings at the time of the transaction. The transaction involved only direct holdings, with no activity reported in indirect accounts such as the ...